Injectable nanoelectrodes for wireless and minimally invasive neural stimulation

Developing minimally invasive, nanoscale, wireless neuroelectrodes for targeted neural stimulation to improve treatment accessibility for neurological impairments.

Subsidie
€ 1.499.725
2023

Projectdetails

Introduction

Neural devices used in the brain and spinal cord have yielded medical breakthroughs to improve the lives of people with spinal cord injury, Parkinson’s disease, and hearing loss. However, current neural devices are large, complex, and invasive, and are therefore used by only a fraction of people who could benefit from them. Instead, I want to make neural devices that are nanoscale, injectable, and wireless. By lowering invasiveness and implantation risk, this technology could address the unmet medical needs of more people with neurological impairments.

Proposed Work

The work proposed herein is to develop a minimally invasive nanoelectrode system capable of wireless, spatially selective, and multiplexed neural stimulation.

Previous Developments

I have previously developed nanoelectrodes that directly stimulated (i.e. with no genetic/biochemical neuron modification) the deep brain of mice as a proof-of-concept. This was possible because, unlike other wireless neural technologies, device powering was nonresonant, and thus independent of size.

Research Approach

In my proposed research, I will now develop optimized nanoelectrodes, and I will approach this by developing a toolbox of nanomaterials to study and learn from. In particular, I will look at how nanoelectrode size and shape affects signal/response and neurostimulation. This approach will generate new, enabling technologies, such as the ability to:

  1. Individually stimulate some particles while ignoring others
  2. Achieve multiplexed stimulation control

Conclusion

While the field of nanoscale and wireless neuroelectrodes is exceptionally small, new, and high risk, the proposed work could one day enable minimally invasive, wireless neural modulation.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.499.725
Totale projectbegroting€ 1.499.725

Tijdlijn

Startdatum1-11-2023
Einddatum31-10-2028
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • TECHNISCHE UNIVERSITAET MUENCHENpenvoerder

Land(en)

Germany

Vergelijkbare projecten binnen European Research Council

ERC STG

MANUNKIND: Determinants and Dynamics of Collaborative Exploitation

This project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery.

€ 1.497.749
ERC STG

Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressure

The UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance.

€ 1.498.280
ERC STG

Uncovering the mechanisms of action of an antiviral bacterium

This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.

€ 1.500.000
ERC STG

The Ethics of Loneliness and Sociability

This project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field.

€ 1.025.860

Vergelijkbare projecten uit andere regelingen

EIC Pathfinder

BioFunctional IntraNeural Electrodes

BioFINE aims to develop advanced flexible intraneural multielectrode arrays for improved long-term integration with peripheral nerves, enhancing bionic limb communication and neurotechnology.

€ 1.945.622
EIC Pathfinder

Wireless deep BRAIN STimulation thrOugh engineeRed Multifunctinal nanomaterials

BRAINSTORM aims to develop a scalable wireless neuromodulation technology using smart magnetic nanomaterials to selectively control deep brain neurons for therapeutic applications in Fragile X syndrome.

€ 3.083.850